Zamboni WC - Search Results

1

Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors.

Zamboni WC, Maruca LJ, Strychor S, Zamboni BA, Ramalingam S, Edwards RP, Kim J, Bang Y, Lee H, Friedland DM, Stoller RG, Belani CP, Ramanathan RK. Zamboni WC, et al. Among authors: zamboni ba. J Liposome Res. 2011 Jun;21(2):158-65. doi: 10.3109/08982104.2010.496085. Epub 2010 Jul 14. J Liposome Res. 2011. PMID: 20626314 Clinical Trial.

2

Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascites.

Delauter BJ, Ramanathan RK, Egorin MJ, Stover LL, Zuhowski EG, Plunkett W, Zamboni WC. Delauter BJ, et al. Among authors: zamboni wc. Pharmacotherapy. 2000 Oct;20(10):1204-7. doi: 10.1592/phco.20.15.1204.34586. Pharmacotherapy. 2000. PMID: 11034044

3

Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma.

Parise RA, Ramanathan RK, Zamboni WC, Egorin MJ. Parise RA, et al. Among authors: zamboni wc. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jan 5;783(1):231-6. doi: 10.1016/s1570-0232(02)00659-1. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12450543

4

Phase I and pharmacologic study of intermittently administered 9-nitrocamptothecin in patients with advanced solid tumors.

Zamboni WC, Jung LL, Egorin MJ, Potter DM, Friedland DM, Belani CP, Agarwala SS, Wong MM, Fakih M, Trump DL, Jin R, Strychor S, Vozniak M, Troetschel M, Ramanathan RK. Zamboni WC, et al. Clin Cancer Res. 2004 Aug 1;10(15):5058-64. doi: 10.1158/1078-0432.CCR-03-0288. Clin Cancer Res. 2004. PMID: 15297407 Clinical Trial.

5

Pharmacokinetic studies of 9-nitrocamptothecin on intermittent and continuous schedules of administration in patients with solid tumors.

Jung LL, Ramanathan RK, Egorin MJ, Jin R, Belani CP, Potter DM, Strychor S, Trump DL, Walko C, Fakih M, Zamboni WC. Jung LL, et al. Among authors: zamboni wc. Cancer Chemother Pharmacol. 2004 Dec;54(6):487-96. doi: 10.1007/s00280-004-0835-9. Epub 2004 Aug 18. Cancer Chemother Pharmacol. 2004. PMID: 15322760 Clinical Trial.

6

Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.

Ramanathan RK, Ramalingam S, Egorin MJ, Belani CP, Potter DM, Fakih M, Jung LL, Strychor S, Jacobs SA, Friedland DM, Shin DM, Chatta GS, Tutchko S, Zamboni WC. Ramanathan RK, et al. Among authors: zamboni wc. Cancer Chemother Pharmacol. 2005 Apr;55(4):354-360. doi: 10.1007/s00280-004-0909-8. Epub 2004 Oct 27. Cancer Chemother Pharmacol. 2005. PMID: 15723261 Clinical Trial.

7

Relationship between plasma exposure of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite and antitumor response in mice bearing human colon carcinoma xenografts.

Zamboni WC, Jung LL, Egorin MJ, Hamburger DR, Joseph E, Jin R, Strychor S, Ramanathan RK, Eiseman JL. Zamboni WC, et al. Clin Cancer Res. 2005 Jul 1;11(13):4867-74. doi: 10.1158/1078-0432.CCR-05-0144. Clin Cancer Res. 2005. PMID: 16000585

8

Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors.

Fakih MG, Creaven PJ, Ramnath N, Trump D, Javle M, Strychor S, Repinski TV, Zamboni BA, Schwarz JK, French RA, Zamboni WC. Fakih MG, et al. Among authors: zamboni wc, zamboni ba. Clin Cancer Res. 2005 Aug 15;11(16):5942-9. doi: 10.1158/1078-0432.CCR-05-0116. Clin Cancer Res. 2005. PMID: 16115937 Clinical Trial.

9

Control-relevant modeling of the antitumor effects of 9-nitrocamptothecin in SCID mice bearing HT29 human colon xenografts.

Harrold JM, Eiseman JL, Joseph E, Strychor S, Zamboni WC, Parker RS. Harrold JM, et al. Among authors: zamboni wc. J Pharmacokinet Pharmacodyn. 2005 Feb;32(1):65-83. doi: 10.1007/s10928-005-2103-y. J Pharmacokinet Pharmacodyn. 2005. PMID: 16205839

10

Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumors.

Zamboni WC, Goel S, Iqbal T, Parise RA, Strychor S, Repinski TV, Egorin MJ, Mani S. Zamboni WC, et al. Cancer Chemother Pharmacol. 2006 May;57(5):631-9. doi: 10.1007/s00280-005-0084-6. Epub 2005 Oct 5. Cancer Chemother Pharmacol. 2006. PMID: 16205924 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page